feed,title,long_url,short_url
Motley,Novo Nordisk's Next-Gen Diabetes Candidate Could Challenge Ozempic -- Is the Stock a Buy?,https://www.fool.com/investing/2024/07/27/novo-nordisks-next-gen-diabetes-candidate-could-ch/?source=iedfolrf0000001,https://da.gd/jvbL
